Small Business Owners Advised to Automate Their Processes to Prosper

Business automation can cover many different issues, from fully automated application deployments to standard operating procedures and many other ways of working more intelligently. What they all have in common is that they can lead to huge savings in time and money

Perth, Australia - September 13, 2017 /PressCable/ —

With many of the world’s biggest companies now using business automation techniques, this is an area of business that has seen dizzying levels of growth in the last few years. Yet, too many small business owners are reported to be reluctant to make this switch.

Business automation can cover many different issues, from fully automated application deployments to standard operating procedures and many other ways of working more intelligently. What they all have in common is that they can lead to huge savings in time and money when carried out well.

It is difficult to calculate exactly how much money has been saved through business automation across the whole economy, as each company has its own approach and many have introduced these improvements little by little. Some sources suggest that a highly automated company has 6 times as many chances of growing their annual revenue by 15% when compared one that hasn’t introduced automation.

According to Craig Ridley, Founder of YourBusinessCoachingClub, “small businesses need to explore the enormous possibilities offered by business automation, rather than seeing it as being something to fear or not relevant to them.”

With modern technology and some sound advice, any type of business can make the switch to automated processes very simply now. Indeed, Mr Ridley identified three key areas to start with, saying that, “creating SOPs, having micro CEOs and automating the lead generation process are all tremendous starting points for anyone looking to include an element of automation in their business for the first time.”

As more and more businesses of all sizes become increasingly automated, the fear is that companies that resist this change could get left behind. The growing trend for automating business is something that appears to be here to stay, so the sooner that entrepreneurs find a way of doing it that works for them the better.

YourBusinessCoachingClub is a cutting edge online business coaching club that aims to better equip entrepreneurs for the demands of the modern business world. With an extensive range of content and valuable coaching sessions, small business owners can discover the answer to many of their questions and concerns on the YourBusinessCoachingClub site.

Contact Info:
Name: Craig Ridley
Organization: PGW Solutions Pty Ltd
Address: GPO Box R1254, Perth, Western Australia 6844

For more information, please visit https://yourbusinesscoachingclub.com/

Source: PressCable

Release ID: 238924

Latest News

EU charges Merck KGaA, GE, Canon of misleading merger info

Sep 25, 2017

By Foo Yun CheeBRUSSELS (Reuters) - General Electric , German drugmaker Merck KGaA , and Japan's Canon risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals.The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules.While the charges will not affect the EU approvals of the deals, they could lead to fines up to 1 percent of global revenue for Merck KGaA and General Electric, and up to...

Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Sep 25, 2017

By Sam NusseyTOKYO (Reuters) - Konica Minolta Inc said it was purchasing U.S. diagnostics company Ambry Genetics in a deal valued at up to $1 billion - an acquisition that marks a strategic shift for the Japanese firm's healthcare business as it seeks a leading position in precision medicine.The deal is the largest ever for the photocopier maker, which has been seeking to diversify away its office equipment business. It pulled out of cameras about a decade ago.Konica Minolta said its advanced imaging technology complemented privately held Ambry's genetic testing capabilities, with initial applications for combining the technologies seen in...

Oxford BioMedica wins big contract for Novartis cell therapy

Sep 25, 2017

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.The deal, announced by Oxford BioMedica on Thursday, could help put the veteran biotech firm on a path to sustainable profitability.The contract is for the supply of lentiviral vectors used to generate CTL019, a new kind of treatment for hard-to-treat leukemia that is expected to reach the market this year.A U.S. advisory panel will discuss the case for approving CTL019 at a meeting...

Novartis receives EU approval for Cosentyx label update

Sep 25, 2017

ZURICH (Reuters) - Novartis said that the Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis.The label update includes 52 week data from the CLEAR study demonstrating the long-term superiority of Cosentyx versus Stelara (ustekinumab) in psoriasis, a common, non-contagious, auto-immune disease, the Swiss pharmaceutials company said on Thursday. (Reporting by Silke Koltrowitz)

FDA puts hold on Merck multiple myeloma trials after deaths

Sep 25, 2017

(Reuters) - Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy.The rare setback for Keytruda sent Merck shares more than 1 percent lower.Merck has been on a roll with the medicine, jumping to the front of the pack of companies with new immuno-oncology drugs, particularly after Keytruda extended survival as an initial treatment for advanced lung cancer, by far the largest oncology market. Bristol-Myers...

Search
Top News
You May Need To Know

About Us

The Healthier Web delivers accurate and up-to-date health information through medical content and insights from experts. Feel the ‘ohm’ here in The Healthier Web.

Contact us: sales@thehealthierweb.com